[HTML][HTML] Updates on uterine artery embolization
MP Kohi, JB Spies - Seminars in Interventional Radiology, 2018 - thieme-connect.com
Uterine fibroids (leiomyomas) are the most common benign neoplasm of the female pelvis
and have a lifetime prevalence exceeding 80% among African American women and …
and have a lifetime prevalence exceeding 80% among African American women and …
Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis
R Das, R Champaneria, JP Daniels… - Cardiovascular and …, 2014 - Springer
Purpose This study was designed to undertake systematic review and meta-analysis of
published comparative trials comparing embolic agents used in uterine artery embolisation …
published comparative trials comparing embolic agents used in uterine artery embolisation …
A case-based approach to common embolization agents used in vascular interventional radiology
A Medsinge, A Zajko, P Orons… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this article is to familiarize the reader with the most commonly
used embolic agents in interventional radiology and discuss an approach for selecting …
used embolic agents in interventional radiology and discuss an approach for selecting …
Comparison of the efficacy of the embolic agents acrylamido polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine artery embolization for …
RL Worthington-Kirsch, GP Siskin, P Hegener… - Cardiovascular and …, 2011 - Springer
Objective To evaluate the efficacy of acrylamido polyvinyl alcohol microspheres (a-PVAM)
as an embolic agent for uterine artery embolization (UAE) compared with Tris-acryl gelatin …
as an embolic agent for uterine artery embolization (UAE) compared with Tris-acryl gelatin …
Preparation of surface‐modified, micrometer‐sized carboxymethyl chitosan drug‐loaded microspheres
Y Cao, Y Ding, L Zhang, G Shi… - Journal of Applied …, 2018 - Wiley Online Library
Drug‐loaded microspheres have attracted much attention in embolization therapy for liver
cancer in recent years. Carboxymethyl chitosan has obvious advantages for biomedical …
cancer in recent years. Carboxymethyl chitosan has obvious advantages for biomedical …
Re-intervention after uterine leiomyoma embolisation is related to incomplete infarction and presence of submucous leiomyomas
M Dueholm, S Langfeldt, HM Mafi, G Eriksen… - European Journal of …, 2014 - Elsevier
Objective To evaluate outcome of invasive gynecological re-interventions after uterine artery
embolisation (UAE) in relation to leiomyoma characteristics. Design A cohort of 114 women …
embolisation (UAE) in relation to leiomyoma characteristics. Design A cohort of 114 women …
Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study
Background Uterine fibroid embolization (UFE) is an effective minimally invasive treatment
aimed to obtain complete fibroid infarction. Purpose To evaluate the degree of fibroid …
aimed to obtain complete fibroid infarction. Purpose To evaluate the degree of fibroid …
Studies on preparations and properties of drug-eluting embolization microspheres made from oxidated alginate and carboxymethyl chitosan
L Guo, S Qin - International Journal of Polymeric Materials and …, 2019 - Taylor & Francis
Embolization microspheres were prepared through two steps. The microspheres
demonstrated regular sphericity with a main size distribution in the range of 100 µm∼ 270 …
demonstrated regular sphericity with a main size distribution in the range of 100 µm∼ 270 …
不可降解动脉栓塞微球的研究进展
彭广娣, 王立强 - 中国新药杂志, 2012 - cqvip.com
动脉栓塞是指将栓塞剂选择性地注入病变靶区供血动脉, 有效阻断血流, 以达到预定治疗目的的
技术, 治疗恶性肿瘤效果显著. 微球作为栓塞剂的治疗效果更加安全有效, 它具有独特的球形外观 …
技术, 治疗恶性肿瘤效果显著. 微球作为栓塞剂的治疗效果更加安全有效, 它具有独特的球形外观 …
[PDF][PDF] ASSESSMENT OF TISSUE DAMAGE TO SURROUNDINGS AFTER IMPLANTATION OF LIQUID EMBOLIC SYSTEM
A Kumari, ML Aggarwal, B Bhat - JOURNAL OF INDIAN …, 2020 - jir.mewaruniversity.org
Biomaterials need to satisfy a number of prerequisites before that can be used in
applications, including biocompatibility. To verify this feature, its components should be …
applications, including biocompatibility. To verify this feature, its components should be …